Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Int J Surg Pathol ; 17(6): 449-51, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19666948

RESUMEN

The diagnosis of follicular carcinoma of the thyroid requires the identification of capsular and/or vascular invasion, with the exception of distant metastases. However, several artifacts may mimic both vascular and capsular invasion. This article presents two cases of pseudo invasion in encapsulated follicular neoplasms. Their differentiation from true vascular and capsular invasion is discussed and the criteria for true invasion are reviewed.


Asunto(s)
Adenocarcinoma Folicular/diagnóstico , Adenoma/diagnóstico , Artefactos , Errores Diagnósticos/prevención & control , Neoplasias de la Tiroides/diagnóstico , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad , Invasividad Neoplásica/diagnóstico
2.
Case Rep Endocrinol ; 2018: 9329035, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30105107

RESUMEN

Hürthle cell predominant thyroid nodules often confound the diagnostic utility of fine needle aspiration biopsy (FNAB) with cytology often interpreted as a Hürthle cell lesion with an indeterminate risk of malignancy, Bethesda category (BC) III or IV. Molecular diagnostics for Hürthle cell predominant nodules has also been disappointing in further defining the risk of malignancy. We present a case of a slowly enlarging nodule within a goiter initially reported as benign on FNAB, BC II but on subsequent FNAB suspicious for a Hürthle cell neoplasm, BC IV. The patient had initially requested a diagnostic lobectomy for a definitive diagnosis despite a higher risk of malignancy based on the size of the nodule > 4 cm alone. To better tailor this patient's treatment plan, a newer expanded gene mutation panel, ThyroSeq® v3 that includes copy number alterations (CNAs) and was recently found to have greater positive predictive value (PPV) for identifying Hürthle cell carcinoma (HCC), was performed on the FNAB material. Molecular profiling with ThyroSeq® v3 was able to predict a greater risk of carcinoma, making a more convincing argument in favor of total thyroidectomy. Surgical pathology confirmed a Hürthle cell carcinoma with 5 foci of angioinvasion and foci of capsular invasion.

3.
Ann Diagn Pathol ; 7(3): 165-8, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12808568

RESUMEN

Polymorphous hemangioendotheliomas are rare, low-grade borderline malignant vascular tumors of endothelial cell origin. To the best of our knowledge (MEDLINE 1966-2002), there have been nine cases of polymorphous hemangioendothelioma reported in the English literature. Most of the initial patients reported were men, but we present the third case in a woman. Her previous radiation history to the neck makes this report unique. Polymorphous hemangioendothelioma is characterized by the variety of patterns of growth within and between tumors, making histologic recognition of the tumor difficult. Because management remains conservative via wide local excision, the misdiagnosis of this lesion as a malignancy has possible treatment implications. Alternatively, the high propensity for local recurrence underscores the necessity for accurate classification of the neoplasm and close clinical follow-up.


Asunto(s)
Neoplasias de Cabeza y Cuello/patología , Hemangioendotelioma/patología , Neoplasias de los Tejidos Blandos/patología , Biomarcadores de Tumor/análisis , Supervivencia sin Enfermedad , Femenino , Neoplasias de Cabeza y Cuello/química , Neoplasias de Cabeza y Cuello/cirugía , Hemangioendotelioma/química , Hemangioendotelioma/cirugía , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Cuello/diagnóstico por imagen , Neoplasias de los Tejidos Blandos/química , Neoplasias de los Tejidos Blandos/cirugía , Tomografía Computarizada por Rayos X
4.
Am J Obstet Gynecol ; 189(1): 155-8, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12861155

RESUMEN

OBJECTIVE: The purpose of this study was to evaluate the correlation between placental and umbilical cord nucleated red blood cell counts. STUDY DESIGN: Eighty placentas and their matched umbilical cord blood samples were collected prospectively immediately after delivery. In vitro fine-needle aspiration biopsy specimens were used to obtain placental tissue samples. Nucleated red blood cells were counted by both manual microscopy and flow cytometry. Statistical analysis included Wilcoxon signed rank test and Spearman correlation. RESULTS: The median nucleated red blood cell counts/100 white blood cell counts for manual microscopy in umbilical cord blood; placental samples were 7.5 and 3.0, respectively (P <.0001). The median nucleated red blood cell counts for flow cytometric determination in umbilical cord blood and placental samples were 11.3 and 8.6, respectively (P <.0001). The Spearman correlation between manually counted umbilical cord blood samples and the placental tissue specimens was 0.66 (P <.0001). The Spearman correlation between flow cytometrically counted umbilical cord blood nucleated red blood cell and nucleated red blood cell counts that were obtained from the placenta was statistically significant (r = 0.74, P <.0001). The Spearman correlation between manual microscopy and flow cytometry for umbilical cord samples and their matched placental tissue specimens were 0.80 and 0.58, respectively, with all probability values at <.0001. CONCLUSION: Previous studies have reported an association between acute and chronic hypoxia and elevated nucleated red blood cells. Our results indicate that in vitro placental nucleated red blood cell counts correlate with umbilical cord nucleated red blood cell counts and suggest that antenatal evaluation of fetal nucleated red blood cells could be achieved by placental fine-needle aspiration biopsy.


Asunto(s)
Biopsia con Aguja , Eritroblastos/citología , Placenta/citología , Adulto , Recuento de Eritrocitos , Femenino , Sangre Fetal/citología , Citometría de Flujo , Humanos , Microscopía , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA